Saturday, June 15, 2024 | Baltimore, MD

Emergent BioSolutions to lay off 400, reduce operations in Baltimore

August 9, 2023

Gaithersburg biotech Emergent BioSolutions (NYSE: EBS) said Tuesday it is significantly reducing its contract development and manufacturing business in a cost-savings measure that will result in about 400 layoffs. Emergent said the move is being made to focus on its core products business, which includes medical countermeasures and opioid overdose antidote Narcan.

Article Source: Baltimore Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.